Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

June 8, 2017

Project reveals importance of cancer gene mutation testing

An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.

By VUMC News and Communications
May 26, 2017

VICC experts to discuss high risk breast cancer at free seminar June 6

Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, will host a free seminar, “Are You at High Risk for Breast Cancer?”

By VUMC News and Communications
May 25, 2017

VUMC wins national recognition for employee health care focus

The CEO Roundtable on Cancer has re-accredited Vanderbilt University Medical Center (VUMC) as a CEO Cancer Gold Standard employer for 2017 for VUMC’s efforts to reduce the risk of cancer for employees and their families.

By VUMC News and Communications
May 18, 2017

Glowing receptors help find and track cancerous growth

Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth.

By Bill Snyder
May 11, 2017

Top cancer researchers reveal latest findings at VICC science retreat

Ordinary cells can be transformed into cancer cells through epigenetics — changes to DNA that turn genes on or off. Those gene changes can protect cells or make them vulnerable to disease processes including cancer.

By VUMC News and Communications
May 4, 2017

Lovly elected to American Society for Clinical Investigation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt, has been elected to The American Society for Clinical Investigation (ASCI).

By VUMC News and Communications
April 27, 2017

Abramson to lead new Department of Radiology innovation program

Richard Abramson, M.D., will engage in creative program development as the Department of Radiology’s first Vice Chair for Innovation.
By Doug Campbell
April 27, 2017

VICC Annual Scientific Retreat slated for May 4

Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center Annual Scientific Retreat, to be held Thursday, May 4.
By VUMC News and Communications
April 24, 2017

Vanderbilt’s Christine Lovly elected to American Society for Clinical Investigation

By VUMC News and Communications
April 20, 2017

Vanderbilt’s W. Kimryn Rathmell named to ASCI leadership post

W. Kimryn Rathmell, director of the Division of Hematology/Oncology at Vanderbilt University Medical Center, has been named vice president of The American Society for Clinical Investigation.
By VUMC News and Communications
April 20, 2017

Study examines new breast cancer drug combination

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.
By VUMC News and Communications
April 13, 2017

Musician, physician collaborate to create message of hope on film

Nashville musician and producer Jesse Boyce compares the anxiety he felt just before receiving palliative radiation therapy to the jitters he often experienced before going on stage. The instant treatment began — and as the first note rang out — his anxiety was replaced by a sense of peace and determination.
By Jill Clendening
April 6, 2017

Vanderbilt’s Pietenpol joins Sledge as a Chief Scientific Advisor for Susan G. Komen

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen.
By VUMC News and Communications